
Briana Costello MD
@bcostelloMD
Followers
8K
Following
21K
Media
353
Statuses
7K
General & Interventional Cardiologist @Texas_Heart 💉❤️, wife, mother, 👧🏽🐱🐶
Houston, TX
Joined February 2011
“There is a movement underway, and it has been growing for a long time.”. PROUD to be a part of the movement. #WIC #SheForShe #HeForShe 👩🏼⚕️🙌🏼
8
23
94
RT @RichardAFerraro: My #Cardiology paper of the year: Daily Step Count in @JACCJournals. The optimal steps to ⬇️ CVD events is NOT THAT HI….
0
101
0
RT @kevinjamescroce: Agent ISR- YES!! Nearly three-quarters of the patients had intravascular image guided ISR PCI….and the outcomes were v….
0
9
0
RT @HanCardiomd: Safety of Continuing #MRA Treatment in Patients with #HFrEF and Severe Kidney Disease . In this study from the Swedish Hea….
0
48
0
RT @thaiscoutinhoCV: 🌟Pub alert! While #preeclampsia (PE)⬆️CVD risk, how do we identify those ♀️whose arteries are already on a disease pat….
0
24
0
RT @MonSangh: Don’t miss this joint AHA/ACC webinar! Achieving gender equity in cardiology requires collaboration with our male allies!….
0
27
0
RT @dr_chebrolu: 📷 "Honored to be in the company of these exceptional #WomenInCardiology. A memorable evening exchanging stories and charti….
0
6
0
RT @EricTopol: Big news #ESC2023 and @NEJM .In a placebo-controlled randomized trial of people with obesity + heart failure (with preserve….
0
171
0
RT @JACCJournals: #ESCCongress #JACC LBCT SimPub:. New from #DAPA-HF & #DELIVER: Benefit-to-risk ratio may favor continuation of #SGLT2i da….
0
12
0
RT @NEJM: Late breaking at #ESCCongress: In patients with heart failure with preserved ejection fraction and obesity, semaglutide (2.4 mg)….
0
300
0
RT @AndrewJSauer: An historic Class 1A recommendation for HFpEF. Expected but still remarkable. #ESCCongress . @escardio . Proud of the man….
0
78
0
RT @JACCJournals: Multicenter real-world audit of #FFRCT by #YesCCT in UK's NICE guidelines shows that PPV of FFRCT was 49%, & its use was….
0
32
0
RT @DrDamluji: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: @JACCJournals. Guide….
0
8
0
RT @brendonneuen: For a 50 year old patient with diabetes & chronic kidney disease, combination treatment with SGLT2 inhibitors & finerenon….
0
109
0
RT @Pooh_Velagapudi: Check out our editorial in #JACCInterventions discussing an interesting manuscript “PPCI in Patients With #SCAD vs CAD….
0
8
0
RT @SandeepNathanMD: Great line from a new patient: “Hi doc. I’m homozygous for a CYP2C19 reduced function allele so you should probably s….
0
8
0
RT @drpablocorral: 👉 Colchicine for CV prevention: the dawn of a new era has finally come. ☝️“The approval of colchicine for secondary CV p….
0
32
0
RT @MWeintraubMD: #Tirzepatide lowered HbA1c to less than 7% in 90% of patients with #type2diabetes and #obesity. Even more impressive: H….
0
130
0
RT @DocSavageTJU: Just out ➡️ Outcomes of Adult Patients With Anomalous RCA #CardioTwitter @fischman_david @mmamas1973 @DrMarthaGulati @Eri….
0
61
0
RT @JACCJournals: Among women w/ premature MIs, 39% had a history of APO. Women w/ APO history presented sooner after pregnancy but had sim….
0
123
0
RT @ArsenaultBenoit: Lipoprotein(a) is risk factor for *early* atherosclerosis. Lipoprotein(a) and carotid intima-media thickness in chil….
0
20
0